# Safety of a Strategy Combining Etanercept Administration With Repeated Contrast Ultrasound in Patients With Alzheimer's Disease

> **NCT06585384** · PHASE1 · RECRUITING · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 5 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **COMBINATION_PRODUCT:** etanercept and repeated contrast ultrasound

## Key facts

- **NCT ID:** NCT06585384
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-15
- **Primary completion:** 2028-06
- **Final completion:** 2028-12
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2026-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06585384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06585384, "Safety of a Strategy Combining Etanercept Administration With Repeated Contrast Ultrasound in Patients With Alzheimer's Disease". Retrieved via MORVS 2026-10-26 from https://api.morvs.ai/clinical/NCT06585384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*